November 18, 2024

Emmecell Announces Positive Topline Results from Randomized, Double-
masked Trial of Groundbreaking Non-surgical Cell Therapy for Corneal Edema.

​

February 20, 2024

Emmecell and Eversight partner to advance ocular cell therapies.

​